PO-HUANG LEEREY-HENG HUMENG-KUN TSAIMING-CHIH HOHONG-SHIEE LAILai M.Y.PEI-MING YANG2019-12-042019-12-0420000041-1345https://www.scopus.com/inward/record.uri?eid=2-s2.0-0033673978&doi=10.1016%2fS0041-1345%2800%2901653-5&partnerID=40&md5=6e2b69a54063ef88b0f05c8c4b8d879ehttps://scholars.lib.ntu.edu.tw/handle/123456789/434668[SDGs]SDG3cyclosporin; hepatitis B antibody; lamivudine; OKT 3; steroid; adult; article; clinical article; female; graft rejection; hepatitis B; human; human tissue; liver transplantation; male; priority journal; recurrent disease; Adult; Antiviral Agents; Cyclosporine; Female; Follow-Up Studies; Hepatitis B; Hepatitis B Antibodies; Hepatitis B e Antigens; Hepatitis B Surface Antigens; Humans; Immunization, Passive; Immunoglobulins; Immunosuppressive Agents; Kidney Transplantation; Lamivudine; Liver Transplantation; Male; Middle Aged; Monitoring, Physiologic; Recurrence; Time Factors; Treatment OutcomeLiver transplantation for patients with hepatitis B: Prevention of hepatitis B recurrence by intravenous antihepatitis B immunoglobulin and lamivudinejournal article10.1016/S0041-1345(00)01653-5111201512-s2.0-0033673978